4AB:ETR
AbbVie Common Stock
266,20 €
0,00%
(0,00) 1 p
17. nov, 17:35:46 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 4AB põhistatistika genereerimine…
Turu kapit.
517,59Â mld
Keskm. maht
581,00
Maht
0,00
52 näd kõrgeim
272,20 €
52 näd madalaim
162,85 €
Töötajate arv
57Â tuh
Turu kapit.
517,59Â mld
Keskm. maht
581,00
Maht
0,00
52 näd kõrgeim
272,20 €
52 näd madalaim
162,85 €
Töötajate arv
57Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Zacks Investment Research
·
13 tunni eest
How Did AbbVie's Neuroscience Franchise Perform in Q3?
The Globe and Mail
·
21 tunni eest
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
Smartkarma
·
4 päeva eest
AbbVie Raises 2026 Revenue Guidance to $67.8 Billion: Can Skyrizi and Rinvoq Sustain Growth?
WSJ
·
2 nädala eest
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Profiil
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Teave üksuse AbbVie Common Stock kohta
TegevjuhtRobert A. Michael
Töötajad57 tuh
Asutatud10. apr 2012
PeakontoridNorth Chicago, Illinois, Ameerika Ühendriigid
SektorHealth Care
Valdkond-
Veebisaitabbvie.com